BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 35382510)

  • 21. Case report: A case of severe retropharyngeal edema after COVID-19 successfully treated with intravenous immunoglobulin.
    Suzuki T; Kono T; Satoshi H; Uchida H; Ota S; Tateya I; Yoshikawa T
    Front Pediatr; 2023; 11():1198505. PubMed ID: 37534196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults.
    Chen CJ; Kao HY; Huang CH; Li CJ; Hung CH; Yong SB
    Ital J Pediatr; 2024 Jan; 50(1):18. PubMed ID: 38273368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic.
    Della Paolera S; Valencic E; Piscianz E; Moressa V; Tommasini A; Sagredini R; Kiren V; Comar M; Taddio A
    Front Pediatr; 2020; 8():624248. PubMed ID: 33708752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case With Typical Clinical Manifestations of Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Temporally Associated With SARS-CoV-2 Infection.
    Kuniyoshi Y; Murata H; Tokutake H; Takahashi N
    Cureus; 2024 Jan; 16(1):e53069. PubMed ID: 38410332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.
    Kwak JH; Lee SY; Choi JW;
    Clin Exp Pediatr; 2021 Feb; 64(2):68-75. PubMed ID: 33445833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Arab Adolescent with Multisystem Inflammatory Syndrome Associated with COVID-19: A Report from Syria.
    Zaino J; Bakri A; Al Sayed Ahmad A; Hadba G
    Avicenna J Med; 2021 Oct; 11(4):221-224. PubMed ID: 34881206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children.
    Takasago S; Sakai A; Sugiyama M; Mizokami M; Hamada H; Ishizaka Y; Miyoshi-Akiyama T; Matsunaga A; Ueno M; Shichino H; Mizukami A
    Front Pediatr; 2021; 9():702318. PubMed ID: 34368030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematuria as an Early Sign of Multisystem Inflammatory Syndrome in Children: A Case Report of a Boy With Multiple Comorbidities and Review of Literature.
    Generalić A; Davidović M; Kos I; Vrljičak K; Lamot L
    Front Pediatr; 2021; 9():760070. PubMed ID: 34778150
    [No Abstract]   [Full Text] [Related]  

  • 29. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG;
    JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves.
    Hennon TR; Yu KOA; Penque MD; Abdul-Aziz R; Chang AC; McGreevy MB; Pastore JV; Prout AJ; Schaefer BA; Alibrahim OS; Gomez-Duarte OG; Hicar MD
    Prog Pediatr Cardiol; 2021 Sep; 62():101407. PubMed ID: 34121829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant Coronary Aneurysms in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection.
    Villacis-Nunez DS; Hashemi S; Nelson MC; Flanagan E; Thakral A; Rodriguez F; Jaggi P; Oster ME; Prahalad S; Rouster-Stevens KA
    JACC Case Rep; 2021 Oct; 3(13):1499-1508. PubMed ID: 34642670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges in Evaluating Pediatric Fever and Rash in the Era of COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C).
    Jarvill T; Lauber P; Umaru S; Villalobos T; Yaeger SK
    Cureus; 2022 Jan; 14(1):e21764. PubMed ID: 35251835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis.
    Abbas M; Törnhage CJ
    Int Med Case Rep J; 2021; 14():55-65. PubMed ID: 33574714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SARS-CoV-2-associated inflammatory multisystem disease in a 15-year-old boy].
    Ormay C; Onozó B; Fitala R; Halász K; Szakos E; Kosztopulosz N; Hauser P
    Orv Hetil; 2021 Apr; 162(16):602-607. PubMed ID: 33830937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19-associated Multisystem Inflammatory Syndrome in Children: A Multicentric Retrospective Cohort Study.
    Mehra B; Pandey M; Gupta D; Oberoi T; Jerath N; Sharma R; Lal N; Singha C; Malhotra B; Manocha V; Simalti AK; Arya Y; Dugaya SK; Kalra S; Chitkara AJ; Sachdev A; Gupta N
    Indian J Crit Care Med; 2021 Oct; 25(10):1176-1182. PubMed ID: 34916752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
    Bukulmez H
    Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease.
    Gupta A; Gill A; Sharma M; Garg M
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32778886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.
    Tolunay O; Çelik Ü; Arslan İ; Orgun A; Demir H; Demir O; Dağdelen EÇ
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.